Page last updated: 2024-11-13

leiurotoxin i

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

leiurotoxin I: 3.4kDa peptide from Leiurus quinquestriatus hebraeus venom; potent apamin binding inhibitor; amino acid sequence given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71311759
MeSH IDM0158654

Synonyms (10)

Synonym
potassium channel toxin alpha-ktx 5.1
leiurotoxin i
scyllatoxin ,
116235-63-3
142948-19-4
scyllatoxin, recombinant, expressed in e. coli, >=95% (hplc), lyophilized powder
lei-i
scytx
letx i
leiurotoxin-1

Research Excerpts

Overview

Leiurotoxin I is a neurotoxin, blocker of Ca(2+)-activated apamin-sensitive K+ channel. purified from the venom of the scorpion Leiurus quinquestriatus hebraeus.

ExcerptReferenceRelevance
"Leiurotoxin I is a neurotoxin, blocker of Ca(2+)-activated apamin-sensitive K+ channel, purified from the venom of the scorpion Leiurus quinquestriatus hebraeus. "( Differential involvement of disulfide bridges on the folding of a scorpion toxin.
Blanc, E; Calabro, V; Darbon, H; Lecomte, C; Sabatier, JM; Van Rietschoten, V, 1997
)
1.74
"Leiurotoxin I (scyllatoxin) is a 31-amino acid polypeptide from the venom of the scorpion Leiurus quinquestriatus hebraeus which has been previously isolated and sequenced by others. "( Leiurotoxin I (scyllatoxin), a peptide ligand for Ca2(+)-activated K+ channels. Chemical synthesis, radiolabeling, and receptor characterization.
Auguste, P; Gesquière, JC; Gravé, B; Hugues, M; Lazdunski, M; Maes, P; Romey, G; Schweitz, H; Tartar, A, 1990
)
3.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.50)18.7374
1990's23 (57.50)18.2507
2000's9 (22.50)29.6817
2010's6 (15.00)24.3611
2020's1 (2.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.38 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index6.10 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]